25 XP   0   0   10

Nevro Corp
Buy, Hold or Sell?

Let's analyse Nevro together

PenkeI guess you are interested in Nevro Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nevro Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nevro Corp

I send you an email if I find something interesting about Nevro Corp.

Quick analysis of Nevro (30 sec.)










What can you expect buying and holding a share of Nevro? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$8.39
Expected worth in 1 year
$7.88
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.51
Return On Investment
-4.0%

For what price can you sell your share?

Current Price per Share
$12.79
Expected price per share
$0 - $14.70
How sure are you?
50%

1. Valuation of Nevro (5 min.)




Live pricePrice per Share (EOD)

$12.79

Intrinsic Value Per Share

$-41.38 - $-14.28

Total Value Per Share

$-32.98 - $-5.89

2. Growth of Nevro (5 min.)




Is Nevro growing?

Current yearPrevious yearGrowGrow %
How rich?$305.4m$279.7m$16.9m5.7%

How much money is Nevro making?

Current yearPrevious yearGrowGrow %
Making money-$23m$750.2k-$23.8m-103.3%
Net Profit Margin-22.4%0.3%--

How much money comes from the company's main activities?

3. Financial Health of Nevro (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#80 / 334

Most Revenue
#73 / 334

Most Profit
#294 / 334

Most Efficient
#178 / 334

What can you expect buying and holding a share of Nevro? (5 min.)

Welcome investor! Nevro's management wants to use your money to grow the business. In return you get a share of Nevro.

What can you expect buying and holding a share of Nevro?

First you should know what it really means to hold a share of Nevro. And how you can make/lose money.

Speculation

The Price per Share of Nevro is $12.79. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nevro.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nevro, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.39. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nevro.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.25-1.9%-0.62-4.9%0.010.1%-0.56-4.4%-0.44-3.5%
Usd Book Value Change Per Share0.544.2%-0.13-1.0%0.141.1%0.080.6%0.161.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.544.2%-0.13-1.0%0.141.1%0.080.6%0.161.3%
Usd Price Per Share21.52-25.58-50.59-83.51-70.55-
Price to Earnings Ratio-21.80--12.12--12.14--41.10--49.72-
Price-to-Total Gains Ratio39.69--59.56-6.67--180.14-2.79-
Price to Book Ratio2.56-3.13-6.92-10.50-9.69-
Price-to-Total Gains Ratio39.69--59.56-6.67--180.14-2.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.79
Number of shares78
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.130.08
Usd Total Gains Per Share-0.130.08
Gains per Quarter (78 shares)-9.906.42
Gains per Year (78 shares)-39.5925.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-40-5002616
20-79-9005142
30-119-13007768
40-158-170010394
50-198-2100128120
60-238-2500154146
70-277-2900180172
80-317-3300205198
90-356-3700231224
100-396-4100257250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%1.041.01.02.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%16.023.01.040.0%18.023.02.041.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.043.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%16.023.01.040.0%18.023.02.041.9%

Fundamentals of Nevro

About Nevro Corp

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-04-04 21:09:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Nevro Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nevro earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nevro to the Medical Devices industry mean.
  • A Net Profit Margin of -7.7% means that $-0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nevro Corp:

  • The MRQ is -7.7%. The company is making a loss. -1
  • The TTM is -22.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7.7%TTM-22.4%+14.6%
TTM-22.4%YOY0.3%-22.7%
TTM-22.4%5Y-22.8%+0.5%
5Y-22.8%10Y-37.1%+14.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.7%-12.4%+4.7%
TTM-22.4%-20.4%-2.0%
YOY0.3%-14.8%+15.1%
5Y-22.8%-21.3%-1.5%
10Y-37.1%-25.0%-12.1%
1.1.2. Return on Assets

Shows how efficient Nevro is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nevro to the Medical Devices industry mean.
  • -1.4% Return on Assets means that Nevro generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nevro Corp:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-4.0%+2.6%
TTM-4.0%YOY-0.2%-3.8%
TTM-4.0%5Y-3.7%-0.3%
5Y-3.7%10Y-4.2%+0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%-4.1%+2.7%
TTM-4.0%-4.7%+0.7%
YOY-0.2%-4.8%+4.6%
5Y-3.7%-4.0%+0.3%
10Y-4.2%-5.2%+1.0%
1.1.3. Return on Equity

Shows how efficient Nevro is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nevro to the Medical Devices industry mean.
  • -3.1% Return on Equity means Nevro generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nevro Corp:

  • The MRQ is -3.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM-7.8%+4.8%
TTM-7.8%YOY-1.5%-6.3%
TTM-7.8%5Y-7.7%-0.1%
5Y-7.7%10Y-7.0%-0.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-4.2%+1.1%
TTM-7.8%-5.8%-2.0%
YOY-1.5%-5.7%+4.2%
5Y-7.7%-6.3%-1.4%
10Y-7.0%-7.1%+0.1%

1.2. Operating Efficiency of Nevro Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nevro is operating .

  • Measures how much profit Nevro makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nevro to the Medical Devices industry mean.
  • An Operating Margin of -10.1% means the company generated $-0.10  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nevro Corp:

  • The MRQ is -10.1%. The company is operating very inefficient. -2
  • The TTM is -23.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-10.1%TTM-23.1%+12.9%
TTM-23.1%YOY-25.6%+2.5%
TTM-23.1%5Y-24.6%+1.5%
5Y-24.6%10Y-35.3%+10.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.1%-24.3%+14.2%
TTM-23.1%-16.4%-6.7%
YOY-25.6%-13.7%-11.9%
5Y-24.6%-19.9%-4.7%
10Y-35.3%-24.5%-10.8%
1.2.2. Operating Ratio

Measures how efficient Nevro is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are $1.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nevro Corp:

  • The MRQ is 1.101. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.240. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.101TTM1.240-0.139
TTM1.240YOY1.250-0.010
TTM1.2405Y1.245-0.005
5Y1.24510Y1.356-0.111
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1011.442-0.341
TTM1.2401.439-0.199
YOY1.2501.431-0.181
5Y1.2451.436-0.191
10Y1.3561.374-0.018

1.3. Liquidity of Nevro Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nevro is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 6.37 means the company has $6.37 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nevro Corp:

  • The MRQ is 6.368. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.729. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.368TTM6.729-0.361
TTM6.729YOY6.945-0.217
TTM6.7295Y5.968+0.760
5Y5.96810Y7.985-2.016
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3682.726+3.642
TTM6.7292.732+3.997
YOY6.9453.510+3.435
5Y5.9683.617+2.351
10Y7.9853.499+4.486
1.3.2. Quick Ratio

Measures if Nevro is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nevro to the Medical Devices industry mean.
  • A Quick Ratio of 7.44 means the company can pay off $7.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nevro Corp:

  • The MRQ is 7.444. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.308. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.444TTM8.308-0.865
TTM8.308YOY8.794-0.486
TTM8.3085Y7.575+0.733
5Y7.57510Y10.670-3.095
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4441.491+5.953
TTM8.3081.633+6.675
YOY8.7942.113+6.681
5Y7.5752.295+5.280
10Y10.6702.255+8.415

1.4. Solvency of Nevro Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nevro assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nevro to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.52 means that Nevro assets are financed with 52.0% credit (debt) and the remaining percentage (100% - 52.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nevro Corp:

  • The MRQ is 0.520. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.492. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.520TTM0.492+0.027
TTM0.492YOY0.509-0.017
TTM0.4925Y0.505-0.012
5Y0.50510Y0.406+0.098
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5200.389+0.131
TTM0.4920.386+0.106
YOY0.5090.335+0.174
5Y0.5050.442+0.063
10Y0.4060.461-0.055
1.4.2. Debt to Equity Ratio

Measures if Nevro is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nevro to the Medical Devices industry mean.
  • A Debt to Equity ratio of 112.7% means that company has $1.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nevro Corp:

  • The MRQ is 1.127. The company is able to pay all its debts with equity. +1
  • The TTM is 0.983. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.127TTM0.983+0.144
TTM0.983YOY1.055-0.072
TTM0.9835Y1.034-0.051
5Y1.03410Y0.772+0.263
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1270.551+0.576
TTM0.9830.554+0.429
YOY1.0550.479+0.576
5Y1.0340.622+0.412
10Y0.7720.674+0.098

2. Market Valuation of Nevro Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nevro generates.

  • Above 15 is considered overpriced but always compare Nevro to the Medical Devices industry mean.
  • A PE ratio of -21.80 means the investor is paying $-21.80 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nevro Corp:

  • The EOD is -12.959. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.804. Based on the earnings, the company is expensive. -2
  • The TTM is -12.124. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.959MRQ-21.804+8.845
MRQ-21.804TTM-12.124-9.680
TTM-12.124YOY-12.143+0.019
TTM-12.1245Y-41.103+28.979
5Y-41.10310Y-49.724+8.621
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-12.959-1.077-11.882
MRQ-21.804-1.704-20.100
TTM-12.124-2.081-10.043
YOY-12.143-2.978-9.165
5Y-41.103-2.379-38.724
10Y-49.724-1.726-47.998
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nevro Corp:

  • The EOD is -7.005. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.786. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.433. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.005MRQ-11.786+4.781
MRQ-11.786TTM-14.433+2.647
TTM-14.433YOY-16.758+2.325
TTM-14.4335Y-39.036+24.604
5Y-39.03610Y-97.836+58.799
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-7.005-0.932-6.073
MRQ-11.786-1.578-10.208
TTM-14.433-2.973-11.460
YOY-16.758-6.318-10.440
5Y-39.036-5.307-33.729
10Y-97.836-5.171-92.665
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nevro is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.56 means the investor is paying $2.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nevro Corp:

  • The EOD is 1.524. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.565. Based on the equity, the company is underpriced. +1
  • The TTM is 3.130. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.524MRQ2.565-1.040
MRQ2.565TTM3.130-0.565
TTM3.130YOY6.923-3.793
TTM3.1305Y10.496-7.366
5Y10.49610Y9.694+0.802
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.5241.876-0.352
MRQ2.5652.372+0.193
TTM3.1302.434+0.696
YOY6.9233.217+3.706
5Y10.4963.893+6.603
10Y9.6944.245+5.449
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Nevro Corp.

3.1. Institutions holding Nevro Corp

Institutions are holding 108.404% of the shares of Nevro Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc11.17450.00194067271-164634-3.8903
2023-12-31BlackRock Inc9.26990.001933740312441257.7998
2023-12-31Armistice Capital, LLC8.72580.93313176000-280000-8.1019
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)8.27260.7152301105954294921.9986
2023-12-31Engaged Capital LLC5.95686.8344216816321681630
2023-12-31Fred Alger Management, LLC5.82250.246121192661065454101.1048
2023-12-31Goldman Sachs Group Inc5.75870.004120960521479162239.7773
2023-09-30BRAIDWELL LP4.88041.079177636800
2023-09-30D. E. Shaw & Co LP3.11320.02271133149621705.805
2023-12-31FMR Inc2.98270.0018108563110060.0928
2023-12-31Rock Springs Capital Management LP2.81610.5431025000-186600-15.4011
2023-12-31State Street Corporation2.76440.00111006169-40764-3.8937
2023-12-31Amvescap Plc.2.58940.0048942471-105627-10.078
2023-12-31Millennium Management LLC2.39050.008187008025466241.3803
2023-12-31Geode Capital Management, LLC2.11180.0017768653390795.3564
2023-12-31Palo Alto Investors, LLC2.06161.454975037136353993.9785
2023-12-31Principal Financial Group Inc1.97960.009972052930860.4301
2023-12-31Balyasny Asset Management LLC1.80190.0265655854-280493-29.9561
2023-12-31Two Sigma Advisers, LLC1.42780.0262519700-5400-1.0284
2023-12-31Two Sigma Investments LLC1.41260.025451415174011.4605
Total 87.312811.941831779968+5167278+16.3%

3.2. Funds holding Nevro Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Explorer Inv3.97180.1455144566317911314.1418
2024-02-29Vanguard Total Stock Mkt Idx Inv2.94960.001107358400
2023-12-31Invesco Global Multi Cap Growth2.46010.5116895431-104569-10.4569
2024-02-29Vanguard Small Cap Index2.43550.009288648481600.929
2024-02-29iShares Russell 2000 ETF2.37770.0202865445-141-0.0163
2023-12-31Alger Weatherbie Specialized Growth A1.75212.3841637729-11126-1.7147
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.45750.00765304822590.0488
2024-02-29Vanguard Small Cap Growth Index Inv1.36720.020849762182801.6921
2023-12-31Meridian Growth Legacy1.20150.68243733100
2024-01-31Fidelity Select Medical Tech and Devcs1.15140.1206419073-580927-58.0927
2024-01-31CS (Lux) Digital Health Equity SB USD0.98910.394636000000
2023-12-31Fidelity Small Cap Index0.96860.029935254342791.2287
2023-12-31Vanguard Strategic Equity Inv0.81510.08229666900
2023-12-31Vanguard VIF Small Co Gr0.79920.414290895158225.7519
2023-12-31Strategic Advisers Small-Mid Cap0.72810.06226499981013.1534
2023-12-31Federated Hermes MDT Small Cap Core IS0.67150.44572444272444270
2023-12-31Federated Hermes MDT SCC Institutional0.67150.44462444272444270
2024-02-29iShares US Medical Devices ETF0.67090.064724419900
2024-02-01iShares Russell 2000 Value ETF0.61760.03282247782840.1265
2023-12-31ArrowMark Small Cap Gro0.59790.74492176272716614.2633
Total 28.65396.617810429407+43555+0.4%

3.3. Insider Transactions

Insiders are holding 3.897% of the shares of Nevro Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-07Shawn MccormickBUY750022.88

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Nevro Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.542-0.127+123%0.139+290%0.082+559%0.163+232%
Book Value Per Share--8.3918.153+3%7.631+10%8.013+5%6.869+22%
Current Ratio--6.3686.729-5%6.945-8%5.968+7%7.985-20%
Debt To Asset Ratio--0.5200.492+6%0.509+2%0.505+3%0.406+28%
Debt To Equity Ratio--1.1270.983+15%1.055+7%1.034+9%0.772+46%
Dividend Per Share----0%-0%-0%-0%
Eps---0.247-0.625+153%0.007-3894%-0.561+127%-0.444+80%
Free Cash Flow Per Share---0.456-0.503+10%0.104-538%-0.235-49%-0.276-39%
Free Cash Flow To Equity Per Share--1.042-0.123+112%0.087+1091%0.126+727%0.205+407%
Gross Profit Margin--1.0001.0000%1.0000%1.560-36%1.280-22%
Intrinsic Value_10Y_max---14.283--------
Intrinsic Value_10Y_min---41.376--------
Intrinsic Value_1Y_max---1.088--------
Intrinsic Value_1Y_min---1.633--------
Intrinsic Value_3Y_max---3.531--------
Intrinsic Value_3Y_min---7.111--------
Intrinsic Value_5Y_max---6.289--------
Intrinsic Value_5Y_min---14.966--------
Market Cap465529141.000-68%783282808.000930967287.250-16%1852332935.250-58%3041617473.300-74%2568868068.200-70%
Net Profit Margin---0.077-0.224+189%0.003-2643%-0.228+195%-0.371+380%
Operating Margin---0.101-0.231+127%-0.256+152%-0.246+142%-0.353+248%
Operating Ratio--1.1011.240-11%1.250-12%1.245-12%1.356-19%
Pb Ratio1.524-68%2.5653.130-18%6.923-63%10.496-76%9.694-74%
Pe Ratio-12.959+41%-21.804-12.124-44%-12.143-44%-41.103+89%-49.724+128%
Price Per Share12.790-68%21.52025.578-16%50.590-57%83.506-74%70.547-69%
Price To Free Cash Flow Ratio-7.005+41%-11.786-14.433+22%-16.758+42%-39.036+231%-97.836+730%
Price To Total Gains Ratio23.588-68%39.688-59.562+250%6.670+495%-180.136+554%2.788+1323%
Quick Ratio--7.4448.308-10%8.794-15%7.575-2%10.670-30%
Return On Assets---0.014-0.040+184%-0.002-83%-0.037+162%-0.042+196%
Return On Equity---0.031-0.078+155%-0.015-51%-0.077+151%-0.070+127%
Total Gains Per Share--0.542-0.127+123%0.139+290%0.082+559%0.163+232%
Usd Book Value--305402000.000296761500.000+3%279795500.000+9%292073250.000+5%250225025.000+22%
Usd Book Value Change Per Share--0.542-0.127+123%0.139+290%0.082+559%0.163+232%
Usd Book Value Per Share--8.3918.153+3%7.631+10%8.013+5%6.869+22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.247-0.625+153%0.007-3894%-0.561+127%-0.444+80%
Usd Free Cash Flow---16615000.000-18313250.000+10%4283250.000-488%-8443600.000-49%-10011975.000-40%
Usd Free Cash Flow Per Share---0.456-0.503+10%0.104-538%-0.235-49%-0.276-39%
Usd Free Cash Flow To Equity Per Share--1.042-0.123+112%0.087+1091%0.126+727%0.205+407%
Usd Market Cap465529141.000-68%783282808.000930967287.250-16%1852332935.250-58%3041617473.300-74%2568868068.200-70%
Usd Price Per Share12.790-68%21.52025.578-16%50.590-57%83.506-74%70.547-69%
Usd Profit---8981000.000-23053250.000+157%750250.000-1297%-20366150.000+127%-15576875.000+73%
Usd Revenue--116176000.000106293500.000+9%101591250.000+14%98537350.000+18%75384825.000+54%
Usd Total Gains Per Share--0.542-0.127+123%0.139+290%0.082+559%0.163+232%
 EOD+2 -6MRQTTM+25 -8YOY+16 -175Y+22 -1210Y+21 -13

4.2. Fundamental Score

Let's check the fundamental score of Nevro Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.959
Price to Book Ratio (EOD)Between0-11.524
Net Profit Margin (MRQ)Greater than0-0.077
Operating Margin (MRQ)Greater than0-0.101
Quick Ratio (MRQ)Greater than17.444
Current Ratio (MRQ)Greater than16.368
Debt to Asset Ratio (MRQ)Less than10.520
Debt to Equity Ratio (MRQ)Less than11.127
Return on Equity (MRQ)Greater than0.15-0.031
Return on Assets (MRQ)Greater than0.05-0.014
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Nevro Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.765
Ma 20Greater thanMa 5013.064
Ma 50Greater thanMa 10014.297
Ma 100Greater thanMa 20016.763
OpenGreater thanClose12.420
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Current Deferred Revenue -5,195-128-5,323-130-5,453-134-5,5877,0691,482
Long-term Assets Other  3,164-553,109-3022,8072,0564,863-27,061-22,198
Tax Provision  356-31325152477-347130-6,708-6,578
Income Tax Expense  356-31325152477-347130-6,708-6,578



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets635,713
Total Liabilities330,311
Total Stockholder Equity293,145
 As reported
Total Liabilities 330,311
Total Stockholder Equity+ 293,145
Total Assets = 635,713

Assets

Total Assets635,713
Total Current Assets530,921
Long-term Assets104,792
Total Current Assets
Cash And Cash Equivalents 104,217
Short-term Investments 218,506
Net Receivables 79,377
Inventory 118,676
Other Current Assets 10,145
Total Current Assets  (as reported)530,921
Total Current Assets  (calculated)530,921
+/-0
Long-term Assets
Property Plant Equipment 33,512
Goodwill 38,164
Intangible Assets 27,354
Other Assets 0
Long-term Assets  (as reported)104,792
Long-term Assets  (calculated)99,030
+/- 5,762

Liabilities & Shareholders' Equity

Total Current Liabilities83,375
Long-term Liabilities246,936
Total Stockholder Equity293,145
Total Current Liabilities
Short-term Debt 5,722
Accounts payable 22,520
Other Current Liabilities 53,651
Total Current Liabilities  (as reported)83,375
Total Current Liabilities  (calculated)81,893
+/- 1,482
Long-term Liabilities
Long term Debt 211,471
Capital Lease Obligations Min Short Term Debt-1,088
Long-term Liabilities Other 43,088
Long-term Liabilities  (as reported)246,936
Long-term Liabilities  (calculated)253,471
+/- 6,535
Total Stockholder Equity
Common Stock36
Retained Earnings -699,410
Accumulated Other Comprehensive Income -243
Other Stockholders Equity 992,762
Total Stockholder Equity (as reported)293,145
Total Stockholder Equity (calculated)293,145
+/-0
Other
Capital Stock36
Cash and Short Term Investments 322,723
Common Stock Shares Outstanding 36,277
Current Deferred Revenue1,482
Liabilities and Stockholders Equity 635,713
Net Debt 117,610
Net Invested Capital 504,616
Net Working Capital 447,546
Property Plant and Equipment Gross 69,174
Short Long Term Debt Total 221,827



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
> Total Assets 
49,111
0
75,411
0
62,904
56,113
202,496
192,220
297,327
287,684
291,183
274,450
412,312
419,861
430,583
417,865
420,772
437,936
454,056
444,845
449,889
451,050
463,116
458,114
447,993
447,738
469,645
459,961
753,172
778,444
789,428
775,672
599,543
582,428
574,544
532,879
523,916
605,512
602,408
574,424
569,518
561,582
635,713
635,713561,582569,518574,424602,408605,512523,916532,879574,544582,428599,543775,672789,428778,444753,172459,961469,645447,738447,993458,114463,116451,050449,889444,845454,056437,936420,772417,865430,583419,861412,312274,450291,183287,684297,327192,220202,49656,11362,904075,411049,111
   > Total Current Assets 
0
0
74,774
0
62,100
53,479
201,125
187,792
291,507
279,191
282,631
265,880
402,478
408,939
420,291
407,359
410,293
426,597
441,181
427,522
431,644
432,817
443,859
409,954
400,684
400,801
422,052
413,560
716,937
742,259
753,106
738,719
556,685
538,867
531,204
490,379
483,302
566,073
562,937
535,457
531,348
521,983
530,921
530,921521,983531,348535,457562,937566,073483,302490,379531,204538,867556,685738,719753,106742,259716,937413,560422,052400,801400,684409,954443,859432,817431,644427,522441,181426,597410,293407,359420,291408,939402,478265,880282,631279,191291,507187,792201,12553,47962,100074,77400
       Cash And Cash Equivalents 
5,618
0
12,409
0
17,394
14,476
25,287
21,984
58,711
87,558
87,036
48,758
50,696
42,733
41,406
19,196
24,869
44,042
42,845
27,650
40,838
21,377
51,266
40,704
62,812
49,338
65,373
136,296
276,515
118,628
44,597
86,537
146,017
80,885
34,710
49,471
109,010
130,839
120,373
64,227
65,186
65,155
104,217
104,21765,15565,18664,227120,373130,839109,01049,47134,71080,885146,01786,53744,597118,628276,515136,29665,37349,33862,81240,70451,26621,37740,83827,65042,84544,04224,86919,19641,40642,73350,69648,75887,03687,55858,71121,98425,28714,47617,394012,40905,618
       Short-term Investments 
24,997
0
44,123
0
24,222
19,216
151,521
137,232
195,239
134,994
106,634
114,439
239,791
245,226
234,951
244,952
238,414
227,312
226,467
231,960
223,018
236,615
213,281
198,892
171,119
183,429
172,429
111,207
285,825
454,243
543,373
489,897
251,487
295,684
327,317
274,171
201,813
256,057
254,012
277,539
264,756
255,103
218,506
218,506255,103264,756277,539254,012256,057201,813274,171327,317295,684251,487489,897543,373454,243285,825111,207172,429183,429171,119198,892213,281236,615223,018231,960226,467227,312238,414244,952234,951245,226239,791114,439106,634134,994195,239137,232151,52119,21624,222044,123024,997
       Net Receivables 
0
0
6,605
0
6,742
5,676
6,610
7,314
7,592
10,525
22,522
29,039
36,855
40,837
52,818
50,824
53,566
53,409
67,287
62,664
66,042
73,993
80,656
69,044
67,052
70,807
82,833
64,682
56,660
78,722
77,667
66,148
65,353
63,460
70,475
63,054
66,903
69,572
78,930
65,725
69,400
68,984
79,377
79,37768,98469,40065,72578,93069,57266,90363,05470,47563,46065,35366,14877,66778,72256,66064,68282,83370,80767,05269,04480,65673,99366,04262,66467,28753,40953,56650,82452,81840,83736,85529,03922,52210,5257,5927,3146,6105,6766,74206,60500
       Other Current Assets 
2,760
0
1,514
0
2,094
1,987
2,851
3,026
3,594
3,463
4,009
6,068
7,014
6,776
5,895
7,652
6,428
6,259
6,463
7,751
6,752
7,226
6,621
8,174
7,348
6,497
9,838
8,392
6,088
6,517
4,173
10,324
8,099
7,036
5,185
13,095
12,056
11,080
9,984
14,673
11,918
10,321
10,145
10,14510,32111,91814,6739,98411,08012,05613,0955,1857,0368,09910,3244,1736,5176,0888,3929,8386,4977,3488,1746,6217,2266,7527,7516,4636,2596,4287,6525,8956,7767,0146,0684,0093,4633,5943,0262,8511,9872,09401,51402,760
   > Long-term Assets 
0
0
637
0
804
2,634
1,371
4,428
5,820
8,493
8,552
8,570
9,834
10,922
10,292
10,506
10,479
11,339
12,875
17,323
18,245
18,233
19,257
48,160
47,309
46,937
47,593
46,401
36,235
36,185
36,322
36,953
42,858
43,561
43,340
42,500
40,614
39,439
39,471
38,967
38,170
39,599
104,792
104,79239,59938,17038,96739,47139,43940,61442,50043,34043,56142,85836,95336,32236,18536,23546,40147,59346,93747,30948,16019,25718,23318,24517,32312,87511,33910,47910,50610,29210,9229,8348,5708,5528,4935,8204,4281,3712,634804063700
       Property Plant Equipment 
108
0
117
0
259
289
647
1,189
2,822
5,686
5,794
5,862
6,688
7,607
7,132
7,390
7,179
7,187
8,819
12,773
13,610
13,312
12,801
36,164
35,136
34,069
33,299
31,868
31,303
31,246
31,673
32,561
37,974
38,499
38,241
37,406
36,333
35,670
35,701
35,252
34,757
34,130
33,512
33,51234,13034,75735,25235,70135,67036,33337,40638,24138,49937,97432,56131,67331,24631,30331,86833,29934,06935,13636,16412,80113,31213,61012,7738,8197,1877,1797,3907,1327,6076,6885,8625,7945,6862,8221,18964728925901170108
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,164
38,164000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,354
27,354000000000000000000000000000000000000000000
       Long-term Assets Other 
0
0
520
0
545
2,345
724
3,239
2,998
2,807
2,758
2,708
3,146
3,315
3,160
3,116
3,300
4,152
4,056
4,550
4,635
4,921
6,456
11,996
12,173
12,868
14,294
14,533
4,932
4,939
4,649
4,392
4,884
5,062
5,099
5,094
4,281
3,163
3,164
3,109
2,807
4,863
-22,198
-22,1984,8632,8073,1093,1643,1634,2815,0945,0995,0624,8844,3924,6494,9394,93214,53314,29412,86812,17311,9966,4564,9214,6354,5504,0564,1523,3003,1163,1603,3153,1462,7082,7582,8072,9983,2397242,345545052000
> Total Liabilities 
5,497
0
7,966
0
8,492
8,756
30,426
33,102
35,800
43,343
56,591
45,670
165,912
172,132
181,549
175,331
179,982
193,697
204,884
202,223
204,300
206,748
217,633
244,015
246,451
249,641
253,293
244,881
378,744
398,664
400,968
409,467
241,167
263,226
270,928
292,493
293,931
280,577
278,532
273,196
274,768
275,916
330,311
330,311275,916274,768273,196278,532280,577293,931292,493270,928263,226241,167409,467400,968398,664378,744244,881253,293249,641246,451244,015217,633206,748204,300202,223204,884193,697179,982175,331181,549172,132165,91245,67056,59143,34335,80033,10230,4268,7568,49207,96605,497
   > Total Current Liabilities 
5,249
0
7,904
0
8,387
8,689
10,798
13,429
16,040
23,496
36,389
25,351
30,553
34,565
42,198
34,204
37,054
48,606
58,004
53,497
53,535
53,795
62,414
65,041
66,223
68,327
70,611
60,909
220,768
239,431
239,165
246,359
73,932
74,847
82,203
70,324
72,666
80,298
79,212
74,919
77,529
79,743
83,375
83,37579,74377,52974,91979,21280,29872,66670,32482,20374,84773,932246,359239,165239,431220,76860,90970,61168,32766,22365,04162,41453,79553,53553,49758,00448,60637,05434,20442,19834,56530,55325,35136,38923,49616,04013,42910,7988,6898,38707,90405,249
       Short-term Debt 
0
0
0
0
0
0
19,511
0
0
0
19,740
0
0
0
138,140
139,820
141,520
143,260
145,019
146,821
148,643
0
0
2,744
0
0
0
0
164,465
166,608
168,776
170,996
0
0
0
0
0
5,070
5,195
5,323
5,453
5,587
5,722
5,7225,5875,4535,3235,1955,07000000170,996168,776166,608164,46500002,74400148,643146,821145,019143,260141,520139,820138,14000019,74000019,511000000
       Short Long Term Debt 
0
0
0
0
0
0
19,511
0
0
0
19,740
0
0
0
138,140
139,820
141,520
143,260
145,019
146,821
148,643
0
0
2,744
0
0
0
0
164,465
166,608
168,776
170,996
0
0
0
0
0
0
0
0
0
0
0
00000000000170,996168,776166,608164,46500002,74400148,643146,821145,019143,260141,520139,820138,14000019,74000019,511000000
       Accounts payable 
1,950
0
3,177
0
3,129
3,496
4,460
8,151
7,256
12,912
21,887
11,774
13,121
13,105
16,162
12,095
11,032
17,800
18,492
22,224
23,543
20,173
23,505
23,074
23,150
19,770
16,048
19,883
18,657
24,473
23,109
29,059
31,029
32,755
31,999
27,135
31,298
31,839
26,849
29,229
30,298
28,854
22,520
22,52028,85430,29829,22926,84931,83931,29827,13531,99932,75531,02929,05923,10924,47318,65719,88316,04819,77023,15023,07423,50520,17323,54322,22418,49217,80011,03212,09516,16213,10513,12111,77421,88712,9127,2568,1514,4603,4963,12903,17701,950
       Other Current Liabilities 
3,002
0
4,727
0
5,258
5,193
6,338
5,278
8,784
10,584
14,502
13,577
17,432
21,460
26,036
22,109
26,022
30,806
39,512
31,273
29,992
33,622
38,909
41,967
43,073
48,557
54,563
41,026
3,781
3,877
3,975
4,066
42,903
42,092
50,204
43,189
41,368
48,459
52,363
45,690
47,231
50,889
53,651
53,65150,88947,23145,69052,36348,45941,36843,18950,20442,09242,9034,0663,9753,8773,78141,02654,56348,55743,07341,96738,90933,62229,99231,27339,51230,80626,02222,10926,03621,46017,43213,57714,50210,5848,7845,2786,3385,1935,25804,72703,002
   > Long-term Liabilities 
0
0
62
0
105
67
19,628
19,673
19,760
19,847
20,202
20,319
135,359
137,567
139,351
141,127
142,928
145,091
146,880
148,726
150,765
152,953
155,219
178,974
180,228
181,314
182,682
183,972
157,976
159,233
161,803
163,108
167,235
188,379
188,725
222,169
221,265
200,279
199,320
198,277
197,239
196,173
246,936
246,936196,173197,239198,277199,320200,279221,265222,169188,725188,379167,235163,108161,803159,233157,976183,972182,682181,314180,228178,974155,219152,953150,765148,726146,880145,091142,928141,127139,351137,567135,35920,31920,20219,84719,76019,67319,6286710506200
       Long term Debt Total 
0
0
0
0
0
0
19,511
19,569
19,628
19,689
19,740
19,801
134,786
136,496
138,140
139,820
141,520
143,260
145,019
146,821
148,643
150,508
152,394
154,325
156,279
158,278
160,300
162,371
137,345
139,504
141,771
144,038
146,422
148,805
151,310
185,953
186,256
186,559
186,867
187,175
0
0
0
000187,175186,867186,559186,256185,953151,310148,805146,422144,038141,771139,504137,345162,371160,300158,278156,279154,325152,394150,508148,643146,821145,019143,260141,520139,820138,140136,496134,78619,80119,74019,68919,62819,56919,511000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-19,511
0
0
0
-19,740
0
0
0
-138,140
-139,820
-141,520
-143,260
-145,019
-146,821
-148,643
0
0
20,262
22,187
21,324
20,445
19,551
-145,831
-148,938
-152,087
-155,297
17,425
16,279
15,402
14,185
12,930
6,554
5,101
3,622
2,098
518
-1,088
-1,0885182,0983,6225,1016,55412,93014,18515,40216,27917,425-155,297-152,087-148,938-145,83119,55120,44521,32422,18720,26200-148,643-146,821-145,019-143,260-141,520-139,820-138,140000-19,740000-19,511000000
       Warrants
0
0
0
0
0
306,732
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000306,73200000
       Long-term Liabilities Other 
0
0
0
0
0
67
117
104
132
158
462
518
573
1,071
1,211
1,307
1,408
1,831
1,861
1,905
2,122
2,445
2,825
24,649
23,949
23,036
22,382
21,601
20,631
19,729
20,032
19,070
3,388
39,574
37,415
36,216
35,009
13,720
12,453
11,102
2,199
2,265
43,088
43,0882,2652,19911,10212,45313,72035,00936,21637,41539,5743,38819,07020,03219,72920,63121,60122,38223,03623,94924,6492,8252,4452,1221,9051,8611,8311,4081,3071,2111,0715735184621581321041176700000
> Total Stockholder Equity
43,614
0
67,445
0
54,412
47,357
172,070
159,118
261,527
244,341
234,592
228,780
246,400
247,729
249,034
242,534
240,790
244,239
249,172
242,622
245,589
244,302
245,483
214,099
201,542
198,097
216,352
215,080
374,428
379,780
388,460
366,205
358,376
319,202
303,616
240,386
229,985
324,935
323,876
301,228
294,750
285,666
293,145
293,145285,666294,750301,228323,876324,935229,985240,386303,616319,202358,376366,205388,460379,780374,428215,080216,352198,097201,542214,099245,483244,302245,589242,622249,172244,239240,790242,534249,034247,729246,400228,780234,592244,341261,527159,118172,07047,35754,412067,445043,614
   Common Stock
1
0
1
0
17
2
25
25
28
28
28
28
28
29
29
29
29
30
30
30
30
30
30
30
31
31
32
32
34
35
35
35
35
35
35
35
35
35
35
36
36
36
36
363636363535353535353535353534323231313030303030303029292929282828282825252170101
   Retained Earnings Total Equity000-642,226-607,197-588,005-669,513-644,523-624,193-594,059-543,984-522,394-492,833-485,704-475,719-434,656-409,768-396,026-378,179-350,158-306,082-296,475-285,210-274,590-257,844-253,533-247,303-235,693-221,186-211,361-207,475-198,696-189,408-175,217-155,763-136,037-121,977-113,65000000
   Accumulated Other Comprehensive Income 
0
0
28
0
17
-21
77
-125
159
-119
-175
-400
-310
-917
-678
-857
-790
-612
-1,242
-1,016
-1,061
-948
-1,077
-556
-738
-538
-313
-1,357
-556
49
598
139
229
-180
-364
-1,577
-3,249
-5,041
-3,094
-2,001
-1,857
-2,152
-243
-243-2,152-1,857-2,001-3,094-5,041-3,249-1,577-364-18022913959849-556-1,357-313-538-738-556-1,077-948-1,061-1,016-1,242-612-790-857-678-917-310-400-175-119159-12577-211702800
   Capital Surplus 
0
0
0
0
0
7,660
293,945
295,255
417,103
419,649
424,147
427,848
454,157
459,978
470,869
479,055
488,854
498,354
508,228
518,198
531,830
541,695
552,612
564,783
580,428
594,630
626,401
651,061
850,669
865,400
880,660
888,425
902,096
913,406
928,138
886,451
902,712
917,946
934,132
945,419
0
0
0
000945,419934,132917,946902,712886,451928,138913,406902,096888,425880,660865,400850,669651,061626,401594,630580,428564,783552,612541,695531,830518,198508,228498,354488,854479,055470,869459,978454,157427,848424,147419,649417,103295,255293,9457,66000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
5,331
0
160,395
7,660
294,357
295,401
417,618
419,906
424,674
428,531
455,319
460,061
471,191
479,198
489,064
498,742
507,986
518,182
531,769
541,747
552,535
565,227
580,690
595,092
626,401
651,061
850,669
865,400
880,660
888,425
902,096
913,406
928,138
886,451
902,712
917,946
934,132
945,419
963,521
978,211
992,762
992,762978,211963,521945,419934,132917,946902,712886,451928,138913,406902,096888,425880,660865,400850,669651,061626,401595,092580,690565,227552,535541,747531,769518,182507,986498,742489,064479,198471,191460,061455,319428,531424,674419,906417,618295,401294,3577,660160,39505,33100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue425,174
Cost of Revenue-146,649
Gross Profit278,525278,525
 
Operating Income (+$)
Gross Profit278,525
Operating Expense-377,833
Operating Income-99,308-99,308
 
Operating Expense (+$)
Research Development54,418
Selling General Administrative334,756
Selling And Marketing Expenses0
Operating Expense377,833389,174
 
Net Interest Income (+$)
Interest Income12,688
Interest Expense-8,014
Other Finance Cost-1,552
Net Interest Income6,226
 
Pretax Income (+$)
Operating Income-99,308
Net Interest Income6,226
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-97,859-100,757
EBIT - interestExpense = -107,322
-97,859
-84,199
Interest Expense8,014
Earnings Before Interest and Taxes (EBIT)-99,308-89,845
Earnings Before Interest and Taxes (EBITDA)-87,773
 
After tax Income (+$)
Income Before Tax-97,859
Tax Provision-1,288
Net Income From Continuing Ops-102,424-99,147
Net Income-92,213
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses524,482
Total Other Income/Expenses Net1,449-6,226
 

Technical Analysis of Nevro
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nevro. The general trend of Nevro is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nevro's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nevro Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.36 < 13.84 < 14.70.

The bearish price targets are: .

Tweet this
Nevro Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nevro Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nevro Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nevro Corp. The current macd is -0.55745588.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nevro price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nevro. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nevro price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nevro Corp Daily Moving Average Convergence/Divergence (MACD) ChartNevro Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nevro Corp. The current adx is 25.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Nevro shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Nevro Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nevro Corp. The current sar is 13.15.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Nevro Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nevro Corp. The current rsi is 43.77. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Nevro Corp Daily Relative Strength Index (RSI) ChartNevro Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nevro Corp. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nevro price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Nevro Corp Daily Stochastic Oscillator ChartNevro Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nevro Corp. The current cci is -62.35405347.

Nevro Corp Daily Commodity Channel Index (CCI) ChartNevro Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nevro Corp. The current cmo is -4.98136541.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Nevro Corp Daily Chande Momentum Oscillator (CMO) ChartNevro Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nevro Corp. The current willr is -56.4516129.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nevro is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Nevro Corp Daily Williams %R ChartNevro Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nevro Corp.

Nevro Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nevro Corp. The current atr is 0.63747524.

Nevro Corp Daily Average True Range (ATR) ChartNevro Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nevro Corp. The current obv is -7,455,922.

Nevro Corp Daily On-Balance Volume (OBV) ChartNevro Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nevro Corp. The current mfi is 33.67.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nevro Corp Daily Money Flow Index (MFI) ChartNevro Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nevro Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Nevro Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nevro Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.765
Ma 20Greater thanMa 5013.064
Ma 50Greater thanMa 10014.297
Ma 100Greater thanMa 20016.763
OpenGreater thanClose12.420
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nevro with someone you think should read this too:
  • Are you bullish or bearish on Nevro? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nevro? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nevro Corp

I send you an email if I find something interesting about Nevro Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Nevro Corp.

Receive notifications about Nevro Corp in your mailbox!